US Stock MarketDetailed Quotes

PEARQ Pear Therapeutics

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose May 24 16:00 ET
142.74Market Cap0.00P/E (TTM)

About Pear Therapeutics Company

Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDTs), which use software to treat diseases directly. The company's vision is to advance healthcare through the widespread use of PDTs and to be the one-stop shop for PDTs offered by Pear and other organizations that may choose to make their products available to patients, providers, and payors via its commercial platform, known as PearConnect. It features four distinct system components, consisting of PDTs for patient use, the PearMD Clinician Dashboard, an end-to-end patient service center, and a data analytics system configured to aggregate patient engagement, adherence, and clinical outcome data.

Company Profile

SymbolPEARQ
Company NamePear Therapeutics
CEODr. Corey McCann, Pd.D
MarketPink Market
Employees200
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Ellen E. Snow
  • Vice President and Chief Accounting Officer
  • --
  • Erin K. Brenner
  • Chief Product Development Officer
  • --
  • Ronan O’Brien, J.D.
  • General Counsel, Secretary and Chief Compliance Officer
  • --
  • Dr. Yuri Maricich, M.D.
  • Chief Medical Officer and Head of Development
  • --
  • Christopher D.T. Guiffre,J.D.,M.B.A.
  • Principal Executive Officer, Chief Financial Officer, Chief Operating Officer, Treasurer and Assistant Secretary
  • --
  • Dr. Corey McCann, Pd.D
  • Director
  • --
  • Zack Lynch
  • Independent Director
  • --
  • Dr. Andrew J. Schwab, PhD
  • Independent Director
  • --
  • Alison Bauerlein
  • Independent Director
  • --
  • Timothy A. Wicks
  • Independent Director
  • --
  • Shivakumar Rajaraman
  • Independent Director
  • --
  • Paul Mango, M.B.A.
  • Independent Director
  • --
  • Nancy M. Schlichting
  • Independent Director
  • --
  • Kirthiga Reddy, M.B.A.
  • Independent Director
  • --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.